A memorandum of understanding (MoU) was signed today between the state government and NIPR at the office of NIPR in Mohali for setting up the composite pharma testing lab, costing Rs 12 crore, on official release said.
All modern facilities would be provided in the lab for testing of pharma products and the state government would bear the entire cost of the project while technical assistance would be provided by NIPR.
Industries Minister Mukesh Agnihotri had raised the issue with Union Chemicals and Fertilizer Minister Anant Kumar last year to set up this laboratory at Baddi.
Additional Director IndustriesTilak Ram Sharma revealed that more than 70 per cent medicines were being manufactured at Baddi and setting up of this laboratory would benefit the entire Pharma industry.
The state government would also soon develop a bulk drug park at Baddi, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
